Author

André Fitsche

University of Zurich

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Achim WeberiD· 1 shared Adrian Kobe· 1 shared Alexander SchmidtiD· 1 shared Andreas Emanuel KremeriD· 1 shared Anne‐Laure LeblondiD· 1 shared Chantal PauliiD· 1 shared Charlotte K.Y. NgiD· 1 shared Chenhui ZhaoiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Achim WeberORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

High regeneration-associated stress defines a distinct HCC subgroup with therapeutically exploitable vulnerabilities

Nina Desboeufs, Peter Leary, Chenhui Zhao, Sarah Kollar, Lap Kwan Chan, Lara Planas‐Paz, André Fitsche, Alexander Schmidt, Fabiola Prutek, Katja R Baumann, S. Schneebeli, Susanne Dettwiler, Federico Donà, Reha Akpinar, Luigi Terracciano, , Achim Weber

This paper identifies a distinct HCC subgroup defined by high regeneration-associated stress, showing vulnerability to ATR inhibitors and proposing LIVRESS as a biomarker for treatment stratification.

bioRxiv · Aug 20, 2026 · PreprintCancer Biology